icone plus
Contact Abonnez-vous aux actualités
Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
zyfZh3ue0G5YKdGM
Écouter
